Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Repasky

Showing results (341-350 of 355) with videos related to

Pageof 36
Sort By:
Oral Oncology|June 20, 2020
Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patientsHye Ri Han, Gregory M Hermann, Sung Jun Ma, et al.
Journal of Computational Chemistry|October 8, 2005
Integrated Modeling Program, Applied Chemical Theory (IMPACT)Jay L Banks, Hege S Beard, Yixiang Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2020
Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor ActivityShipra Gandhi, Manu R Pandey, Kristopher Attwood, et al.
Oral Oncology|August 7, 2022
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiationSung Jun Ma, Han Yu, Michael Khan, et al.
Infectious Diseases and Therapy|May 29, 2020
Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic ReviewDavid C Fajgenbaum, Johnson S Khor, Alexander Gorzewski, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2022
Radiation Therapy Exacerbates Tumor-Promoting Innervation and Nerve Signaling in Rectal CancerTaylor P Uccello, Maggie L Lesch, Nicholas A Ullman, et al.
Cellular & Molecular Immunology|January 17, 2024
CD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunityG Aaron Holling, Colin A Chavel, Anand P Sharda, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2018
Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER ConsortiumChi-Chen Hong, Lara E Sucheston-Campbell, Song Liu, et al.
Cell Death & Disease|July 26, 2023
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapyTaylor P Uccello, Maggie L Lesch, Sarah A Kintzel, et al.
Cell Chemical Biology|December 26, 2017
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target InteractionsJing Tang, Zia-Ur-Rehman Tanoli, Balaguru Ravikumar, et al.
Pageof 36

Showing results (341-350 of 355) with videos related to

Sort By:
Pageof 36
Oral Oncology|June 20, 2020
Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patientsHye Ri Han, Gregory M Hermann, Sung Jun Ma, et al.
Journal of Computational Chemistry|October 8, 2005
Integrated Modeling Program, Applied Chemical Theory (IMPACT)Jay L Banks, Hege S Beard, Yixiang Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2020
Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor ActivityShipra Gandhi, Manu R Pandey, Kristopher Attwood, et al.
Oral Oncology|August 7, 2022
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiationSung Jun Ma, Han Yu, Michael Khan, et al.
Infectious Diseases and Therapy|May 29, 2020
Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic ReviewDavid C Fajgenbaum, Johnson S Khor, Alexander Gorzewski, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2022
Radiation Therapy Exacerbates Tumor-Promoting Innervation and Nerve Signaling in Rectal CancerTaylor P Uccello, Maggie L Lesch, Nicholas A Ullman, et al.
Cellular & Molecular Immunology|January 17, 2024
CD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunityG Aaron Holling, Colin A Chavel, Anand P Sharda, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2018
Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER ConsortiumChi-Chen Hong, Lara E Sucheston-Campbell, Song Liu, et al.
Cell Death & Disease|July 26, 2023
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapyTaylor P Uccello, Maggie L Lesch, Sarah A Kintzel, et al.
Cell Chemical Biology|December 26, 2017
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target InteractionsJing Tang, Zia-Ur-Rehman Tanoli, Balaguru Ravikumar, et al.
Pageof 36